These peptides are often used in wellness and performance settings to support recovery, lean muscle maintenance, sleep quality, and healthy aging
AOD-9604 is a promising peptide for individuals seeking targeted fat loss without the risks associated with traditional growth hormone therapy
Long-term safety data is still limited, and the novel glucagon-agonist component introduces uncertainties about long-term effects
In preclinical and ex vivo models, GLP-1R agonism has been linked to augmented glucose-dependent insulin secretion, suppressed glucagon release from pancreatic alpha cells, and delayed gastric emptying
18 Used together, this represents a ready-to-use model to boost bioavailability of oral peptides
About 15% of patients experience nervous system involvement, such as Bells palsy, and 8% have myocardial abnormalities